What we are researching
The purpose of this study is to learn about the safety and tolerability of the study medicine in people, with higher-than-normal uric acid levels.
Who may participate
Each clinical trial has its own requirements for who can participate, often called eligibility criteria. Some of the key criteria for this study are listed here. Discuss these requirements with your study doctor to determine if you may be eligible to participate. Additional criteria for your doctor to review can be found here NCT06859073.
Age
25 to 75 years
Current Health and Medical History
Have never been diagnosed with gout or chronic kidney disease, and have not used medicine to lower uric acid
Uric Acid Level
Have higher-than-normal uric acid levels, based on tests done at study visits 1 and 2
Study Medicine
One or more injections
Number of study visits
About 11 visits over a period of about 7 months
What to expect
If your study doctor determines that you are eligible and you decide to participate, you may be enrolled into the study.
Once enrolled, you will be randomly assigned to receive either the study medicine at one of five dose levels or placebo (which has no active medicine in it). All are given as one or multiple injections under the skin.
Your participation is expected to last about 7 months, and will involve one overnight stay (lasting 3 nights). During the follow-up period after your stay, you will have in-person visits every 11 to 28 days. Visits may include physical exams, lab tests and questionnaires to monitor your health and safety.
Call 866-867-7178 or email clinicaltrials@novonordisk.com to learn more
about the study and find out whether there is a participating study site near you.
When you call, please reference study 8071
You may also choose to discuss this clinical trial with your healthcare provider.